{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T06:38:31Z","timestamp":1795156711731,"version":"4.10.3"},"reference-count":149,"publisher":"Annual Reviews","issue":"1","license":[{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,12]]},"abstract":"<jats:p>Evidence from epidemiological, clinical, and biological research resulted in the immune hypothesis: the hypothesis that immune system dysfunction is involved in the pathophysiology of schizophrenia spectrum disorders (SSD). The promising implication of this hypothesis is the potential to use existing immunomodulatory treatment for innovative interventions for SSD. Here, we provide a selective historical review of important discoveries that have shaped our understanding of immune dysfunction in SSD. We first explain the basic principles of immune dysfunction, after which we travel more than a century back in time. Starting our journey with neurosyphilis-associated psychosis in the nineteenth century, we continue by evaluating the role of infections and autoimmunity in SSD and findings from assessment of immune function using new techniques, such as cytokine levels, microglia density, neuroimaging, and gene expression. Drawing from these findings, we discuss anti-inflammatory interventions for SSD, and we conclude with a look into the future.<\/jats:p>","DOI":"10.1146\/annurev-clinpsy-081122-013201","type":"journal-article","created":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T14:20:17Z","timestamp":1720794017000},"page":"229-257","source":"Crossref","is-referenced-by-count":49,"title":["Immune Dysfunction in Schizophrenia Spectrum Disorders"],"prefix":"10.1146","volume":"20","author":[{"given":"S.S.","family":"Gangadin","sequence":"first","affiliation":[{"name":"1Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; email: i.e.c.sommer@umcg.nl"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.D.","family":"Enthoven","sequence":"additional","affiliation":[{"name":"1Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; email: i.e.c.sommer@umcg.nl"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.J.M.","family":"van Beveren","sequence":"additional","affiliation":[{"name":"2Department of Neuroscience, Erasmus MC, Rotterdam, The Netherlands"},{"name":"3Parnassia Group for Mental Health Care, The Hague and Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.D.","family":"Laman","sequence":"additional","affiliation":[{"name":"4Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.E.C.","family":"Sommer","sequence":"additional","affiliation":[{"name":"1Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; email: i.e.c.sommer@umcg.nl"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22","reference":[{"issue":"4","key":"B1","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1007\/s12035-022-03199-2","article-title":"Brain inflammatory marker abnormalities in major psychiatric diseases: a systematic review of postmortem brain studies","volume":"60","year":"2023","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"B2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/oxfordjournals.schbul.a033347","article-title":"Changes in the risk of schizophrenia in Scotland: Is there an environmental factor?","volume":"24","year":"1998","journal-title":"Schizophr. Bull."},{"issue":"4","key":"B3","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1021\/acschemneuro.6b00056","article-title":"In vivo imaging of human neuroinflammation","volume":"7","year":"2016","journal-title":"ACS Chem. Neurosci."},{"issue":"3","key":"B4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S2215-0366(20)30006-7","article-title":"Cytokine concentrations throughout pregnancy and risk for psychosis in adult offspring: a longitudinal case-control study","volume":"7","year":"2020","journal-title":"Lancet Psychiatry"},{"issue":"7","key":"B5","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S2215-0366(18)30057-9","article-title":"Preventive strategies for mental health","volume":"5","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"11","key":"B6","doi-asserted-by":"crossref","first-page":"8508","DOI":"10.1002\/jcp.26791","article-title":"Serum C-reactive protein in the prediction of cardiovascular diseases: overview of the latest clinical studies and public health practice","volume":"233","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"B7","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.neuroscience.2015.06.028","article-title":"The neuropathology of schizophrenia: a selective review of past studies and emerging themes in brain structure and cytoarchitecture","volume":"303","year":"2015","journal-title":"Neuroscience"},{"key":"B8","first-page":"141","article-title":"Role of infection, autoimmunity, atopic disorders, and the immune system in schizophrenia: evidence from epidemiological and genetic studies","volume-title":"Neuroinflammation and Schizophrenia","year":"2019"},{"issue":"1","key":"B9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1749-6632.2012.06638.x","article-title":"Autoimmune diseases and infections as risk factors for schizophrenia","volume":"1262","year":"2012","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"B10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.schres.2019.02.005","article-title":"A genetics perspective on the role of the (neuro)immune system in schizophrenia","volume":"217","year":"2020","journal-title":"Schizophr. Res."},{"issue":"6","key":"B11","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1093\/schbul\/sbt195","article-title":"Hospital admission with infection during childhood and risk for psychotic illness\u2014a population-based cohort study","volume":"40","year":"2014","journal-title":"Schizophr. Bull."},{"issue":"1","key":"B12","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12974-017-0962-y","article-title":"Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder","volume":"14","year":"2017","journal-title":"J. Neuroinflammation"},{"issue":"7","key":"B13","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1017\/S0033291722000897","article-title":"Role of the gut microbiome in three major psychiatric disorders","volume":"52","year":"2022","journal-title":"Psychol. Med."},{"key":"B14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev-clinpsy-080621-045153","article-title":"Psychoneuroimmunology: an introduction to immune-to-brain communication and its implications for clinical psychology","volume":"19","year":"2023","journal-title":"Annu. Rev. Clin. Psychol."},{"issue":"1","key":"B15","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/s42003-023-04852-9","article-title":"Regulation of synaptic connectivity in schizophrenia spectrum by mutual neuron-microglia interaction","volume":"6","year":"2023","journal-title":"Commun. Biol."},{"issue":"3","key":"B16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1176\/appi.ajp.2009.09030361","article-title":"Prenatal infection and schizophrenia: a review of epidemiologic and translational studies","volume":"167","year":"2010","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"B17","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/00005053-194206000-00001","article-title":"The group of dementia praecox patients with an increase of the protein content of the cerebrospinal fluid","volume":"95","year":"1942","journal-title":"J. Nerv. Ment. Dis."},{"key":"B18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.euroneuro.2020.03.010","article-title":"Persistent negative symptoms in recent-onset psychosis: relationship to treatment response and psychosocial functioning","volume":"34","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B19","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.bbi.2020.04.039","article-title":"Altered peripheral blood compounds in drug-na\u00efve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis","volume":"88","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"B20","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1017\/S0033291721000155","article-title":"Changes in peripheral blood compounds following psychopharmacological treatment in drug-na\u00efve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis","volume":"51","year":"2021","journal-title":"Psychol. Med."},{"issue":"14","key":"B21","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1017\/S0033291719001995","article-title":"An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis","volume":"49","year":"2019","journal-title":"Psychol. Med."},{"issue":"2","key":"B22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1176\/ajp.135.2.165","article-title":"Antipsychotic drugs, neurotransmitters, and schizophrenia","volume":"135","year":"1978","journal-title":"Am. J. Psychiatry"},{"key":"B23","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/s41386-022-01272-x","article-title":"White-matter free-water diffusion MRI in schizophrenia: a systematic review and meta-analysis","volume":"47","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"B24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.schres.2021.05.014","article-title":"Prenatal infection and schizophrenia: a decade of further progress","volume":"247","year":"2022","journal-title":"Schizophr. Res."},{"issue":"1\u20133","key":"B25","first-page":"255","article-title":"Maternal exposure to sexually transmitted infections and schizophrenia among offspring","volume":"166","year":"2015","journal-title":"Schizophr. Res."},{"key":"B26","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","article-title":"Microglia function in the central nervous system during health and neurodegeneration","volume":"35","year":"2017","journal-title":"Annu. Rev. Immunol."},{"key":"B27","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.neubiorev.2021.03.004","article-title":"Impaired regulatory T cell control of astroglial overdrive and microglial pruning in schizophrenia","volume":"125","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"B28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1176\/appi.ajp.2007.07050740","article-title":"Infections in the CNS during childhood and the risk of subsequent psychotic illness: a cohort study of more than one million Swedish subjects","volume":"165","year":"2008","journal-title":"Am. J. Psychiatry"},{"issue":"11","key":"B29","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(19)30244-3","article-title":"An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models","volume":"18","year":"2019","journal-title":"Lancet Neurol."},{"key":"B30","doi-asserted-by":"crossref","first-page":"00438","DOI":"10.3389\/fpsyt.2018.00438","article-title":"Putative astroglial dysfunction in schizophrenia: a meta-analysis of 1H-MRS studies of medial prefrontal myo-inositol","volume":"9","year":"2018","journal-title":"Front. Psychiatry"},{"issue":"10","key":"B31","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1001\/jamapsychiatry.2021.1590","article-title":"Association of Toxoplasma gondii seropositivity with cognitive function in healthy people","volume":"78","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"7","key":"B32","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1001\/jamapsychiatry.2015.0526","article-title":"Absence of N-methyl-d-aspartate receptor IgG autoantibodies in schizophrenia","volume":"72","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"11","key":"B33","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S2215-0366(18)30345-6","article-title":"The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trial","volume":"5","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"B34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bbi.2018.02.013","article-title":"Rethinking IL-6 and CRP: why they are more than inflammatory biomarkers, and why it matters","volume":"70","year":"2018","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"B35","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/schbul\/sbaa134","article-title":"Large-scale evidence for an association between peripheral inflammation and white matter free water in schizophrenia and healthy individuals","volume":"47","year":"2021","journal-title":"Schizophr. Bull."},{"issue":"7","key":"B36","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1073\/pnas.1010529108","article-title":"Normal gut microbiota modulates brain development and behavior","volume":"108","year":"2011","journal-title":"PNAS"},{"key":"B37","doi-asserted-by":"crossref","first-page":"115064","DOI":"10.1016\/j.psychres.2023.115064","article-title":"Bridging the gaps towards precision psychiatry: mechanistic biomarkers for early detection and intervention","volume":"321","year":"2023","journal-title":"Psychiatry Res."},{"issue":"10","key":"B38","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1046\/j.1460-9568.2000.00229.x","article-title":"Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo","volume":"12","year":"2000","journal-title":"Eur. J. Neurosci."},{"issue":"11","key":"B39","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.2967\/jnumed.109.066647","article-title":"Neuroinflammation in schizophrenia-related psychosis: a PET study","volume":"50","year":"2009","journal-title":"J. Nucl. Med."},{"issue":"5","key":"B40","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/ijnp\/pyad012","article-title":"Redox and immune signaling in schizophrenia: new therapeutic potential","volume":"26","year":"2023","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B41","doi-asserted-by":"crossref","first-page":"880568","DOI":"10.3389\/fpsyt.2022.880568","article-title":"Immune system abnormalities in schizophrenia: an integrative view and translational perspectives","volume":"13","year":"2022","journal-title":"Front. Psychiatry"},{"issue":"6","key":"B42","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/bpa.12198","article-title":"Alterations in immune cells and mediators in the brain: It's not always neuroinflammation!","volume":"24","year":"2014","journal-title":"Brain Pathol."},{"issue":"4","key":"B43","first-page":"319","article-title":"Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?","volume":"17","year":"1983","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"B44","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/wps.20571","article-title":"Diet as a hot topic in psychiatry: a population-scale study of nutritional intake and inflammatory potential in severe mental illness","volume":"17","year":"2018","journal-title":"World Psychiatry"},{"issue":"3","key":"B45","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tem.2016.09.005","article-title":"Inflammaging and \u2018garb-aging","volume":"28","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"issue":"6420","key":"B46","doi-asserted-by":"crossref","first-page":"eaat8127","DOI":"10.1126\/science.aat8127","article-title":"Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder","volume":"362","year":"2018","journal-title":"Science"},{"key":"B47","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.schres.2022.12.009","article-title":"Lower fractional anisotropy without evidence for neuro-inflammation in patients with early-phase schizophrenia spectrum disorders","volume":"264","year":"2024","journal-title":"Schizophr. Res."},{"issue":"3","key":"B48","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/YCO.0000000000000498","article-title":"MRI investigation of immune dysregulation in schizophrenia","volume":"32","year":"2019","journal-title":"Curr. Opin. Psychiatry"},{"issue":"3","key":"B49","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/YCO.0000000000000696","article-title":"Abnormal synaptic pruning during adolescence underlying the development of psychotic disorders","volume":"34","year":"2021","journal-title":"Curr. Opin. Psychiatry"},{"key":"B50","doi-asserted-by":"crossref","first-page":"108048","DOI":"10.1016\/j.pharmthera.2021.108048","article-title":"Imaging neuroinflammation with TSPO: a new perspective on the cellular sources and subcellular localization","volume":"234","year":"2022","journal-title":"Pharmacol. Ther."},{"issue":"6","key":"B51","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1017\/S0033291719003969","article-title":"Brain free water alterations in first-episode psychosis: a longitudinal analysis of diagnosis, course of illness, and medication effects","volume":"51","year":"2021","journal-title":"Psychol. Med."},{"key":"B52","doi-asserted-by":"crossref","first-page":"113192","DOI":"10.1016\/j.psychres.2020.113192","article-title":"Accumulation rate of advanced glycation end products in recent onset psychosis: a longitudinal study","volume":"291","year":"2020","journal-title":"Psychiatry Res."},{"issue":"4","key":"B53","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S2215-0366(23)00025-1","article-title":"Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis","volume":"10","year":"2023","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"B54","doi-asserted-by":"crossref","first-page":"8","DOI":"10.24869\/psyd.2023.8","article-title":"Monoclonal antibody therapy in autoantibody-associated psychotic disorders and schizophrenia: narrative review of past and current clinical trials","volume":"35","year":"2023","journal-title":"Psychiatr. Danub."},{"issue":"4","key":"B55","doi-asserted-by":"crossref","first-page":"e227503","DOI":"10.1001\/jamanetworkopen.2022.7503","article-title":"Association of maternal autoimmune diseases with risk of mental disorders in offspring in Denmark","volume":"5","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"5","key":"B56","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1038\/s41380-022-01494-x","article-title":"Schizophrenia: a disorder of broken brain bioenergetics","volume":"27","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"B57","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3390\/genes12020259","article-title":"Schizophrenia: complement cleaning or killing","volume":"12","year":"2021","journal-title":"Genes"},{"issue":"3","key":"B58","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/schbul\/sbp006","article-title":"The dopamine hypothesis of schizophrenia: version III\u2014the final common pathway","volume":"35","year":"2009","journal-title":"Schizophr. Bull."},{"issue":"2","key":"B59","doi-asserted-by":"crossref","first-page":"e1024","DOI":"10.1038\/tp.2016.278","article-title":"Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization","volume":"7","year":"2017","journal-title":"Transl. Psychiatry"},{"issue":"6","key":"B60","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1176\/appi.psy.42.6.453","article-title":"Syphilis in clinical psychiatry: a review","volume":"42","year":"2001","journal-title":"Psychosomatics"},{"issue":"7321","key":"B61","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature09552","article-title":"Rethinking schizophrenia","volume":"468","year":"2010","journal-title":"Nature"},{"issue":"8","key":"B62","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1371\/journal.pmed.0020124","article-title":"Why most published research findings are false","volume":"2","year":"2005","journal-title":"PLOS Med."},{"key":"B63","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.euroneuro.2020.11.001","article-title":"Towards precision medicine: what are the stratification hypotheses to identify homogeneous inflammatory subgroups","volume":"45","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B64","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.schres.2022.12.005","article-title":"Altered expression of microglial markers of phagocytosis in schizophrenia","volume":"251","year":"2023","journal-title":"Schizophr. Res."},{"key":"B65","doi-asserted-by":"crossref","first-page":"00131","DOI":"10.3389\/fpsyt.2019.00131","article-title":"Autoimmune diseases and psychotic disorders","volume":"10","year":"2019","journal-title":"Front. Psychiatry"},{"key":"B66","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.bbi.2020.08.028","article-title":"Efficacy and safety of anti-inflammatory agents in treatment of psychotic disorders\u2014a comprehensive systematic review and meta-analysis","volume":"90","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"B67","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","article-title":"A blood\u2013brain barrier overview on structure, function, impairment, and biomarkers of integrity","volume":"17","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"B68","doi-asserted-by":"crossref","first-page":"137011","DOI":"10.1016\/j.neulet.2022.137011","article-title":"The immune-stress\/endocrine-redox-metabolic nature of psychosis\u2019 etiopathology; focus on the intersystemic pathways interactions","volume":"794","year":"2023","journal-title":"Neurosci. Lett."},{"key":"B69","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41593-021-00847-z","article-title":"Brain gene co-expression networks link complement signaling with convergent synaptic pathology in schizophrenia","volume":"24","year":"2021","journal-title":"Nat. Neurosci."},{"issue":"10","key":"B70","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"B71","first-page":"395","article-title":"Is schizophrenia an autoimmune disease? A review","volume":"6","year":"1984","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"issue":"2","key":"B72","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/acps.12671","article-title":"Infections and exposure to anti-infective agents and the risk of severe mental disorders: a nationwide study","volume":"135","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"B73","volume-title":"Dementia Praecox and Paraphrenia","year":"1919"},{"key":"B74","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.schres.2022.06.026","article-title":"Could CRP be a differential biomarker of illness stages in schizophrenia? A systematic review and meta-analysis","volume":"246","year":"2022","journal-title":"Schizophr. Res."},{"key":"B75","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.euroneuro.2020.01.007","article-title":"Duration of untreated psychosis and response to treatment: an analysis of response in the OPTiMiSE cohort","volume":"32","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"4","key":"B76","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.biopsych.2018.09.013","article-title":"Parental infections before, during, and after pregnancy as risk factors for mental disorders in childhood and adolescence: a nationwide Danish study","volume":"85","year":"2019","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"B77","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.schres.2014.09.046","article-title":"Comparing free water imaging and magnetization transfer measurements in schizophrenia","volume":"161","year":"2015","journal-title":"Schizophr. Res."},{"issue":"13","key":"B78","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1017\/S0033291718003057","article-title":"Neuroinflammation in schizophrenia: meta-analysis of in vivo microglial imaging studies","volume":"49","year":"2019","journal-title":"Psychol. Med."},{"issue":"6","key":"B79","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/schbul\/sbad019","article-title":"Microstructural and microvascular alterations in psychotic spectrum disorders: a three-compartment intravoxel incoherent imaging and free water model","volume":"49","year":"2023","journal-title":"Schizophr. Bull."},{"issue":"7","key":"B80","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3390\/diagnostics11071134","article-title":"Upregulation of sICAM-1 and sVCAM-1 levels in the cerebrospinal fluid of patients with schizophrenia spectrum disorders","volume":"11","year":"2021","journal-title":"Diagnostics"},{"key":"B81","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bbi.2016.09.008","article-title":"Serum C-reactive protein in adolescence and risk of schizophrenia in adulthood: a prospective birth cohort study","volume":"59","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"B82","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41380-022-01887-y","article-title":"Burning down the house: reinventing drug discovery in psychiatry for the development of targeted therapies","volume":"28","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"B83","doi-asserted-by":"crossref","first-page":"105200","DOI":"10.1016\/j.psyneuen.2021.105200","article-title":"Immune-inflammatory markers and psychosis risk: a systematic review and meta-analysis","volume":"127","year":"2021","journal-title":"Psychoneuroendocrinology"},{"issue":"10","key":"B84","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1002\/glia.23007","article-title":"Critical data-based re-evaluation of minocycline as a putative specific microglia inhibitor","volume":"64","year":"2016","journal-title":"Glia"},{"issue":"1","key":"B85","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/jamapsychiatry.2020.2459","article-title":"Development of proteomic prediction models for transition to psychotic disorder in the clinical high-risk state and psychotic experiences in adolescence","volume":"78","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"B86","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1176\/appi.ajp.159.6.1029","article-title":"Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia","volume":"159","year":"2002","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"B87","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/schbul\/sbad049","article-title":"Compositional and functional alterations in intestinal microbiota in patients with psychosis or schizophrenia: a systematic review and meta-analysis","volume":"49","year":"2023","journal-title":"Schizophr. Bull."},{"issue":"1","key":"B88","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12974-018-1067-y","article-title":"A clinical approach to new-onset psychosis associated with immune dysregulation: the concept of autoimmune psychosis","volume":"15","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"B89","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.schres.2021.01.024","article-title":"The effect of prednisolone on symptom severity in schizophrenia: a placebo-controlled, randomized controlled trial","volume":"230","year":"2021","journal-title":"Schizophr. Res."},{"issue":"2","key":"B90","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/schbul\/sbx069","article-title":"Systemic biomarkers of accelerated aging in schizophrenia: a critical review and future directions","volume":"44","year":"2018","journal-title":"Schizophr. Bull."},{"issue":"6","key":"B91","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1093\/schbul\/sbt200","article-title":"Hospital contacts with infection and risk of schizophrenia: a population-based cohort study with linkage of Danish national registers","volume":"40","year":"2014","journal-title":"Schizophr. Bull."},{"issue":"3","key":"B92","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/0957154X07078705","article-title":"Kraepelin's \u2018lost biological psychiatry\u2019? Autointoxication, organotherapy and surgery for dementia praecox","volume":"18","year":"2007","journal-title":"Hist. Psychiatry"},{"key":"B93","article-title":"Astrocytes in schizophrenia","volume":"5","year":"2021","journal-title":"Brain Neurosci. Adv."},{"issue":"6","key":"B94","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/s41380-018-0220-4","article-title":"Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis","volume":"24","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"B95","doi-asserted-by":"crossref","first-page":"796466","DOI":"10.3389\/fpsyt.2021.796466","article-title":"Schizophrenia increases variability of the central antioxidant system: a meta-analysis of variance from MRS studies of glutathione","volume":"12","year":"2021","journal-title":"Front. Psychiatry"},{"issue":"21","key":"B96","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1016\/j.neuron.2022.10.020","article-title":"Microglia states and nomenclature: a field at its crossroads","volume":"110","year":"2022","journal-title":"Neuron"},{"issue":"3","key":"B97","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.schres.2015.05.034","article-title":"In vivo imaging of neuroinflammation in schizophrenia","volume":"173","year":"2016","journal-title":"Schizophr. Res."},{"issue":"1","key":"B98","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.schres.2012.02.019","article-title":"Schizophrenia in patients with atopic disorders with particular emphasis on asthma: a Danish population-based study","volume":"138","year":"2012","journal-title":"Schizophr. Res."},{"key":"B99","doi-asserted-by":"crossref","first-page":"63","DOI":"10.31887\/DCNS.2018.20.1\/bpenninx","article-title":"Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications","volume":"20","year":"2018","journal-title":"Dialogues Clin. Neurosci."},{"issue":"3","key":"B100","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/jamapsychiatry.2016.3803","article-title":"Impaired glucose homeostasis in first-episode schizophrenia","volume":"74","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"B101","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.biopsych.2018.02.1171","article-title":"Positron emission tomography studies of the glial cell marker translocator protein in patients with psychosis: a meta-analysis using individual participant data","volume":"84","year":"2018","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"B102","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.biopsych.2020.05.028","article-title":"Meta-analysis of the glial marker TSPO in psychosis revisited: reconciling inconclusive findings of patient\u2013control differences","volume":"89","year":"2021","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"B103","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S2215-0366(19)30290-1","article-title":"Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin","volume":"7","year":"2020","journal-title":"Lancet Psychiatry"},{"issue":"6511","key":"B104","doi-asserted-by":"crossref","first-page":"eaay4014","DOI":"10.1126\/science.aay4014","article-title":"The science and medicine of human immunology","volume":"369","year":"2020","journal-title":"Science"},{"issue":"3","key":"B105","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/YCO.0000000000000789","article-title":"Brain vasculature disturbance in schizophrenia","volume":"35","year":"2022","journal-title":"Curr. Opin. Psychiatry"},{"issue":"2","key":"B106","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/jnen\/59.2.137","article-title":"Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics","volume":"59","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"4","key":"B107","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/ije\/26.4.837","article-title":"Association between central nervous system infections during childhood and adult onset schizophrenia and other psychoses: a 28-year follow-up","volume":"26","year":"1997","journal-title":"Int. J. Epidemiol."},{"key":"B108","first-page":"00566","article-title":"The indispensable roles of microglia and astrocytes during brain development","volume":"10","year":"2016","journal-title":"Front. Hum. Neurosci."},{"key":"B109","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bbi.2020.08.019","article-title":"Overexpression of complement component C4 in the dorsolateral prefrontal cortex, parietal cortex, superior temporal gyrus and associative striatum of patients with schizophrenia","volume":"90","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"B110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.schres.2017.11.023","article-title":"Cytokines dysregulation in schizophrenia: a systematic review of psychoneuroimmune relationship","volume":"197","year":"2018","journal-title":"Schizophr. Res."},{"key":"B111","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1038\/s41380-023-02059-2","article-title":"Biomarkers in the cerebrospinal fluid of patients with psychotic disorders compared to healthy controls: a systematic review and meta-analysis","volume":"28","year":"2023","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"B112","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nn.4277","article-title":"Schizophrenia genetics complements its mechanistic understanding","volume":"19","year":"2016","journal-title":"Nat. Neurosci."},{"issue":"7510","key":"B113","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature13595","article-title":"Biological insights from 108 schizophrenia-associated genetic loci","volume":"511","year":"2014","journal-title":"Nature"},{"key":"B114","first-page":"9949453","article-title":"N-acetylcysteine: a review of clinical usefulness (an old drug with new tricks)","volume":"2021","year":"2021","journal-title":"J. Nutr. Metab."},{"issue":"7589","key":"B115","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature16549","article-title":"Schizophrenia risk from complex variation of complement component 4","volume":"530","year":"2016","journal-title":"Nature"},{"issue":"3","key":"B116","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41593-018-0334-7","article-title":"Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning","volume":"22","year":"2019","journal-title":"Nat. Neurosci."},{"issue":"2","key":"B117","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1192\/bjp.187.2.101","article-title":"Social defeat: risk factor for schizophrenia?","volume":"187","year":"2005","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"B118","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.schres.2012.02.025","article-title":"Gastrointestinal inflammation and associated immune activation in schizophrenia","volume":"138","year":"2012","journal-title":"Schizophr. Res."},{"issue":"2","key":"B119","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/MOG.0000000000000244","article-title":"A gut (microbiome) feeling about the brain","volume":"32","year":"2016","journal-title":"Curr. Opin. Gastroenterol."},{"issue":"8","key":"B120","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1017\/S1368980013002115","article-title":"Designing and developing a literature-derived, population-based dietary inflammatory index","volume":"17","year":"2014","journal-title":"Public Health Nutr"},{"key":"B121","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.schres.2019.10.045","article-title":"Microglial activation in schizophrenia: Is translocator 18 kDa protein (TSPO) the right marker?","volume":"215","year":"2020","journal-title":"Schizophr. Res."},{"issue":"5","key":"B122","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/glia.23962","article-title":"A loss of mature microglial markers without immune activation in schizophrenia","volume":"69","year":"2021","journal-title":"Glia"},{"issue":"1","key":"B123","doi-asserted-by":"crossref","first-page":"16003","DOI":"10.1038\/npjschz.2016.3","article-title":"Early interventions in risk groups for schizophrenia: What are we waiting for?","volume":"2","year":"2016","journal-title":"NPJ Schizophr."},{"issue":"4","key":"B124","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1093\/schbul\/sbab010","article-title":"Simvastatin augmentation for patients with early-phase schizophrenia-spectrum disorders: a double-blind, randomized placebo-controlled trial","volume":"47","year":"2021","journal-title":"Schizophr. Bull."},{"issue":"12","key":"B125","doi-asserted-by":"crossref","first-page":"28841","DOI":"10.3390\/ijms161226136","article-title":"The historical development of immunoendocrine concepts of psychiatric disorders and their therapy","volume":"16","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"B126","doi-asserted-by":"crossref","first-page":"sgaa042","DOI":"10.1093\/schizbullopen\/sgaa042","article-title":"Toxoplasma gondii infection and clinical characteristics of patients with schizophrenia: a systematic review and meta-analysis","volume":"1","year":"2020","journal-title":"Schizophr. Bull. Open"},{"issue":"2","key":"B127","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00127-019-01819-2","article-title":"Experiences of taking neuroleptic medication and impacts on symptoms, sense of self and agency: a systematic review and thematic synthesis of qualitative data","volume":"55","year":"2020","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"B128","volume-title":"Parasites, Pussycats and Psychosis: The Unknown Dangers of Human Toxoplasmosis","year":"2022"},{"issue":"3","key":"B129","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/schbul\/sbl050","article-title":"Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis","volume":"33","year":"2007","journal-title":"Schizophr. Bull."},{"issue":"11","key":"B130","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3201\/eid0911.030143","article-title":"Toxoplasma gondii and schizophrenia","volume":"9","year":"2003","journal-title":"Emerg. Infect. Dis."},{"issue":"7906","key":"B131","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/s41586-022-04434-5","article-title":"Mapping genomic loci implicates genes and synaptic biology in schizophrenia","volume":"604","year":"2022","journal-title":"Nature"},{"issue":"2","key":"B132","first-page":"245","article-title":"Julius Wagner-Jauregg and the legacy of malarial therapy for the treatment of general paresis of the insane","volume":"86","year":"2013","journal-title":"Yale J. Biol. Med."},{"issue":"9","key":"B133","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.biopsych.2008.04.025","article-title":"Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study","volume":"64","year":"2008","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"B134","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1124\/pharmrev.120.000063","article-title":"Pharmacological modulation of immune responses by nutritional components","volume":"73","year":"2021","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"B135","doi-asserted-by":"crossref","first-page":"e1075","DOI":"10.1038\/tp.2017.4","article-title":"Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies","volume":"7","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"B136","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.schres.2019.05.028","article-title":"The association between schizophrenia and the immune system: review of the evidence from unbiased \u2018omic-studies.\u2019","volume":"217","year":"2020","journal-title":"Schizophr. Res."},{"issue":"3","key":"B137","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/YCO.0000000000000791","article-title":"Unhealthy diet in schizophrenia spectrum disorders","volume":"35","year":"2022","journal-title":"Curr. Opin. Psychiatry"},{"issue":"2\u20133","key":"B138","first-page":"189","article-title":"Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis","volume":"113","year":"2009","journal-title":"Schizophr. Res."},{"issue":"1","key":"B139","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archpsyc.63.1.25","article-title":"Dynamically spreading frontal and cingulate deficits mapped in adolescents with schizophrenia","volume":"63","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"issue":"7","key":"B140","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/archpsyc.1987.01800190080012","article-title":"Implications of normal brain development for the pathogenesis of schizophrenia","volume":"44","year":"1987","journal-title":"Arch. Gen. Psychiatry"},{"key":"B141","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.schres.2018.10.023","article-title":"The effect of minocycline on symptoms in schizophrenia: results from a randomized controlled trial","volume":"206","year":"2019","journal-title":"Schizophr. Res."},{"issue":"4","key":"B142","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/schbul\/sbaa198","article-title":"Adjunctive aspirin versus placebo in patients with schizophrenia: results of two randomized controlled trials","volume":"47","year":"2021","journal-title":"Schizophr. Bull."},{"key":"B143","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1146\/annurev-immunol-101320-125133","article-title":"Sex differences in immunity","volume":"40","year":"2022","journal-title":"Annu. Rev. Immunol."},{"issue":"5","key":"B144","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/schbul\/sbt120","article-title":"Elevated C-reactive protein associated with late- and very-late-onset schizophrenia in the general population: a prospective study","volume":"40","year":"2014","journal-title":"Schizophr. Bull."},{"key":"B145","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12974-021-02309-6","article-title":"The semantics of microglia activation: neuroinflammation, homeostasis, and stress","volume":"18","year":"2021","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"B146","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1128\/CMR.8.1.131","article-title":"Viruses, schizophrenia, and bipolar disorder","volume":"8","year":"1995","journal-title":"Clin. Microbiol. Rev."},{"key":"B147","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.psyneuen.2017.04.014","article-title":"Metabolic adverse effects of olanzapine on cognitive dysfunction: a possible relationship between BDNF and TNF-alpha","volume":"81","year":"2017","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"B148","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41398-022-02305-1","article-title":"Serum complement proteins rather than inflammatory factors is effective in predicting psychosis in individuals at clinical high risk","volume":"13","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"B149","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbi.2023.03.018","article-title":"Increased prefrontal cortical cells positive for macrophage\/microglial marker CD163 along blood vessels characterizes a neuropathology of neuroinflammatory schizophrenia","volume":"111","year":"2023","journal-title":"Brain Behav. Immun."}],"container-title":["Annual Review of Clinical Psychology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.annualreviews.org\/content\/journals\/10.1146\/annurev-clinpsy-081122-013201?crawler=true&mimetype=application\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T04:08:19Z","timestamp":1759464499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.annualreviews.org\/content\/journals\/10.1146\/annurev-clinpsy-081122-013201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,12]]},"references-count":149,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,7,12]]}},"URL":"https:\/\/doi.org\/10.1146\/annurev-clinpsy-081122-013201","relation":{},"ISSN":["1548-5943","1548-5951"],"issn-type":[{"value":"1548-5943","type":"print"},{"value":"1548-5951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,12]]}}}